<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) August 11, 2000
----------------
ABIOMED, INC.
-------------
(Exact name of registrant as specified in its charter)
DELAWARE 0-20584 04-2743260
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission IRS Employer
of incorporation) File Number) Identification Number)
22 CHERRY HILL DRIVE
DANVERS, MASSACHUSETTS 01923
----------------------------
(Address of principal executive offices, including zip code)
(978) 777-5410
--------------
(Registrant's telephone number, including area code)
Not Applicable
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
<PAGE>
ITEM 5. OTHER EVENTS.
At the Company's Annual Meeting of Shareholders held on August 9, 2000,
the stockholders approved the following:
a) Elected two persons to serve as Class II directors as follows:
<TABLE>
<CAPTION>
DIRECTOR VOTES FOR VOTES WITHHELD
-------- --------- --------------
<S> <C> <C>
John F. O'Brien 9,547,645 180,745
Henri A. Termeer 9,549,189 179,201
</TABLE>
b) A proposal to amend the Company's Restated Certificate of
Incorporation to increase the number of authorized shares of common stock from
25,000,000 to 100,000,000. The proposal received 9,136,973 votes for and 583,375
votes against. There were 8,042 abstentions.
c) A proposal to approve the ABIOMED, Inc. 2000 Stock Incentive Plan.
The proposal received 5,186,976 votes for and 767,910 votes against. There were
34,806 abstentions.
1
<PAGE>
ABIOMED, INC.
--------------------------------------------------------------------------------
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunder duly authorized.
ABIOMED, Inc.
Date: August 11, 2000 /s/DAVID M. LEDERMAN
------------------------------
David M. Lederman
CEO and President
2
